Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases

Lauren A Dalvin1,2, Li-Anne S Lim1, Michael Chang1

  • 1Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, United States.

Insights

Younger patients with circumscribed choroidal hemangioma (CCH) experience worse vision and larger tumors. Early detection and tailored treatments are crucial for this pediatric subgroup.

Area of Science:

  • Ophthalmology
  • Oncology
  • Medical Research

Background:

  • Circumscribed choroidal hemangioma (CCH) is a benign vascular tumor of the choroid.
  • Tumor characteristics and patient outcomes can vary significantly based on age at diagnosis.

Purpose of the Study:

  • To investigate the distinct features and treatment outcomes of CCH in relation to patient age at presentation.
  • To identify potential differences in clinical presentation and management strategies across different age groups.

Main Methods:

  • A retrospective review was conducted on 458 cases of CCH diagnosed between 1967 and 2018.
  • Patients were stratified into three age groups: ≤20 years, >20-50 years, and >50 years.
  • Clinical data, including tumor characteristics, visual acuity, treatment modalities, and follow-up outcomes, were analyzed.

Main Results:

  • The youngest age group (≤20 years) presented with significantly worse visual acuity, larger tumor basal diameter, greater tumor thickness, and closer proximity to the foveola.
  • Younger patients were more likely to receive plaque or external beam radiotherapy and required more treatment sessions.
  • Despite differences in initial presentation and treatment intensity, long-term visual acuity loss of 3 or more Snellen lines did not significantly differ across age groups.

Conclusions:

  • Pediatric patients (≤20 years) with CCH exhibit unique clinical features, including poorer visual acuity and more extensive tumors.
  • The findings highlight the need for improved early detection and age-specific treatment strategies for CCH in younger individuals.
  • Further research is warranted to optimize management protocols for this vulnerable patient subgroup.
Abstract

Related Concept Videos